Details for New Drug Application (NDA): 214092
✉ Email this page to a colleague
The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for 214092
Tradename: | CARBIDOPA AND LEVODOPA |
Applicant: | Sciegen Pharms Inc |
Ingredient: | carbidopa; levodopa |
Patents: | 0 |
Suppliers and Packaging for NDA: 214092
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET;ORAL | 214092 | ANDA | A-S Medication Solutions | 50090-5969 | 50090-5969-1 | 90 TABLET in 1 BOTTLE (50090-5969-1) |
CARBIDOPA AND LEVODOPA | carbidopa; levodopa | TABLET;ORAL | 214092 | ANDA | A-S Medication Solutions | 50090-5969 | 50090-5969-2 | 270 TABLET in 1 BOTTLE (50090-5969-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG;100MG | ||||
Approval Date: | May 7, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;100MG | ||||
Approval Date: | May 7, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;250MG | ||||
Approval Date: | May 7, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription